{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T20:04:34Z","timestamp":1784405074234,"version":"3.55.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T00:00:00Z","timestamp":1528416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T00:00:00Z","timestamp":1528416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Peyronie\u2019s disease (PD) is a chronic fibrotic disease of the penis affecting a significant number of men worldwide without effective medical treatments. Myofibroblasts are pivotal in the pathogenesis of PD. Adenosine and adenosine receptors have been suggested to be involved in the pathophysiology of fibrosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To understand the role of adenosine receptors in myofibroblast transformation in PD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Fibroblasts were isolated from the non-PD tunica albuginea (TA) tissue and PD plaque tissue and were transformed into myofibroblasts using transforming growth factor (TGF)-\u03b21. Quantification of \u03b1-smooth muscle actin and adenosine receptors (adenosine receptor A1 [ADORA1], adenosine receptor A2A, adenosine receptor A2B [ADORA2B], and adenosine receptor A3) was performed using immuno-cytochemistry, in-cell enzyme-linked immuno-sorbent assay (ICE), and real-time reverse transcription quantitative polymerase chain reaction. The effect of various adenosine receptor agonists or antagonists on TGF-\u03b21-induced myofibroblast transformation was measured using ICE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcomes<\/jats:title>\n                  <jats:p>Expression of adenosine receptors in myofibroblasts obtained from human TA and the effect of adenosine receptor ligands on myofibroblast transformation were investigated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The experiments showed that the protein and messenger RNA levels of \u03b1-smooth muscle actin in non-PD TA cells and PD plaque-derived cells were significantly higher in cells exposed to TGF-\u03b21 than those not treated with TGF-\u03b21. 2 of 4 adenosine receptors (ADORA1 and ADORA2B) were found to be expressed in both cell populations. Among various adenosine receptor agonists\/antagonist investigated, only ADORA2B agonist, BAY 60-6583, significantly inhibited myofibroblast transformation in a concentration-dependent manner when applied simultaneously with TGF-\u03b21 (IC50\u00a0= 30 \u03bcmol\/L).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Translation<\/jats:title>\n                  <jats:p>ADORA2B agonists may be clinically efficacious in early-stage PD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths &amp;\u00a0Limitations<\/jats:title>\n                  <jats:p>The strength of this study is the use of primary fibroblasts from human TA. Limitation of the study is the high concentrations of the ligands used.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The effect of an ADORA2B agonist on TGF-\u03b21-induced myofibroblast transformation shows a novel potential therapeutic target for PD if applied during early, non-stable phase of PD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1016\/j.jsxm.2018.05.003","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T11:55:49Z","timestamp":1528458949000},"page":"947-957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Understanding the Role of Adenosine Receptors in the Myofibroblast Transformation in Peyronie\u2019s Disease"],"prefix":"10.1093","volume":"15","author":[{"given":"Marta","family":"Mateus","sequence":"first","affiliation":[{"name":"Anglia Ruskin University \u00a0 , Chelmsford , United Kingdom"},{"name":"Faculty of Medical Science \u00a0 , Chelmsford , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus M.","family":"Ilg","sequence":"additional","affiliation":[{"name":"Anglia Ruskin University \u00a0 , Chelmsford , United Kingdom"},{"name":"Faculty of Medical Science \u00a0 , Chelmsford , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Stebbeds","sequence":"additional","affiliation":[{"name":"Cranfield University , Bedfordshire , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nim","family":"Christopher","sequence":"additional","affiliation":[{"name":"University College London Hospital , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Muneer","sequence":"additional","affiliation":[{"name":"University College London Hospital , London , United Kingdom"},{"name":"National Institute for Health Research Biomedical Research Center University College London Hospitals , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Ralph","sequence":"additional","affiliation":[{"name":"University College London Hospital , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Cellek","sequence":"additional","affiliation":[{"name":"Anglia Ruskin University \u00a0 , Chelmsford , United Kingdom"},{"name":"Faculty of Medical Science \u00a0 , Chelmsford , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,8]]},"reference":[{"key":"2023012309495650800_bib1","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"2023012309495650800_bib2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jcp.22322","article-title":"The origin of fibroblasts and mechanism of cardiac fibrosis","volume":"225","author":"Krenning","year":"2010","journal-title":"J\u00a0Cell Physiol"},{"key":"2023012309495650800_bib3","first-page":"23","article-title":"Myofibroblasts in health and disease","volume":"3","author":"Shirol","year":"2012","journal-title":"Int J Oral Maxillofac Pathol"},{"key":"2023012309495650800_bib4","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1073\/pnas.1702750114","article-title":"Small molecule-mediated inhibition of myofibroblast transdifferentiation for the treatment of fibrosis","volume":"114","author":"Bollong","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"2023012309495650800_bib5","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/ijcp.12129","article-title":"Understanding the course of Peyronie\u2019s disease","volume":"67","author":"Garaffa","year":"2013","journal-title":"Int J Clin Pract"},{"key":"2023012309495650800_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.maturitas.2014.05.024","article-title":"Peyronie\u2019s disease: review and recent advances","volume":"78","author":"Langston","year":"2014","journal-title":"Maturitas"},{"key":"2023012309495650800_bib7","first-page":"313","article-title":"The transcriptional signatures of cells from the human Peyronie\u2019s disease plaque and the ability of these cells to generate a plaque in a rat model suggest potential therapeutic targets","volume":"12","author":"Gelfand","year":"2015","journal-title":"J\u00a0Sex Med"},{"key":"2023012309495650800_bib8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s11934-004-0074-y","article-title":"New discoveries in the basic science understanding of Peyronie\u2019s disease","volume":"5","author":"Jalkut","year":"2004","journal-title":"Curr Urol Rep"},{"key":"2023012309495650800_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ncpuro0201","article-title":"Mechanisms of disease: new insights into the cellular and molecular pathology of Peyronie\u2019s disease","volume":"2","author":"Gonzalez-Cadavid","year":"2005","journal-title":"Nat Clin Pract Urol"},{"key":"2023012309495650800_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.ijir.3900874","article-title":"Peyronie\u2019s disease cell culture models: phenotypic, genotypic and functional analyses","volume":"14","author":"Mulhall","year":"2002","journal-title":"Int J Impot Res"},{"key":"2023012309495650800_bib11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1089-8603(02)00124-6","article-title":"Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie\u2019s fibrotic plaque and in its rat model","volume":"7","author":"Vernet","year":"2002","journal-title":"Nitric Oxide"},{"key":"2023012309495650800_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3410\/B3-21","article-title":"Adenosine receptors and fibrosis: a translational review","volume":"3","author":"Cronstein","year":"2011","journal-title":"F1000 Biol Rep"},{"key":"2023012309495650800_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00109-013-0997-1","article-title":"Adenosine signaling during acute and chronic disease states","volume":"91","author":"Karmouty-Quintana","year":"2013","journal-title":"J\u00a0Mol Med"},{"key":"2023012309495650800_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrd3955","article-title":"Adenosine receptors as drug targets\u2014what are the challenges?","volume":"12","author":"Chen","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"2023012309495650800_bib15","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1371\/journal.pmed.0050137","article-title":"The reno-vascular A2B adenosine receptor protects the kidney from ischemia","volume":"5","author":"Grenz","year":"2008","journal-title":"PLoS Med"},{"key":"2023012309495650800_bib16","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.4049\/jimmunol.1002907","article-title":"Distinct roles for the A2B adenosine receptor in acute and chronic stages of bleomycin-induced lung injury","volume":"186","author":"Zhou","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"2023012309495650800_bib17","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/CIRCULATIONAHA.106.669697","article-title":"Cardioprotection by ecto-5\u2019-nucleotidase (CD73) and A2B adenosine receptors","volume":"115","author":"Eckle","year":"2007","journal-title":"Circulation"},{"key":"2023012309495650800_bib18","doi-asserted-by":"crossref","first-page":"G285","DOI":"10.1152\/ajpgi.00348.2003","article-title":"Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction","volume":"286","author":"Day","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2023012309495650800_bib19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1124\/jpet.111.191288","article-title":"GS-6201, a selective blocker of the A2B adenosine receptor, attenuates cardiac remodeling after acute myocardial infarction in the mouse","volume":"343","author":"Toldo","year":"2012","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"2023012309495650800_bib20","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2353\/ajpath.2008.070952","article-title":"Pharmacological blockade of A2A receptors prevents dermal fibrosis in a model of elevated tissue adenosine","volume":"172","author":"Fern\u00e1ndez","year":"2008","journal-title":"Am J Pathol"},{"key":"2023012309495650800_bib21","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.bjp.0706812","article-title":"Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis","volume":"148","author":"Chan","year":"2006","journal-title":"Br J Pharmacol"},{"key":"2023012309495650800_bib22","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1172\/JCI27303","article-title":"Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury","volume":"116","author":"Sun","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"2023012309495650800_bib23","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1096\/fj.09-144147","article-title":"Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling","volume":"24","author":"Wen","year":"2010","journal-title":"FASEB J"},{"key":"2023012309495650800_bib24","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1681\/ASN.2010080890","article-title":"A2B adenosine receptor-mediated induction of IL-6 promotes CKD","volume":"22","author":"Dai","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"2023012309495650800_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01665905","article-title":"An improved method of establishing human fibroblast cultures from explants","volume":"6","author":"Cheung","year":"1980","journal-title":"J\u00a0Tissue Cult Methods"},{"key":"2023012309495650800_bib26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2023012309495650800_bib27","doi-asserted-by":"crossref","first-page":"e9965","DOI":"10.1371\/journal.pone.0009965","article-title":"Quantification of rapid myosin regulatory light chain phosphorylation using high-throughput in-cell Western assays: comparison to Western immunoblots","volume":"5","author":"Aguilar","year":"2010","journal-title":"PLoS One"},{"key":"2023012309495650800_bib28","doi-asserted-by":"crossref","first-page":"458276","DOI":"10.1155\/2012\/458276","article-title":"Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic disease","volume":"2012","author":"Sampson","year":"2012","journal-title":"Oxid Med Cell Longev"},{"key":"2023012309495650800_bib29","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1172\/JCI72267","article-title":"Cellular and molecular mechanisms in kidney fibrosis","volume":"124","author":"Duffield","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"2023012309495650800_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1165\/rcmb.2004-0103OC","article-title":"Synergy between A2B adenosine receptors and hypoxia in activating human lung fibroblasts","volume":"32","author":"Zhong","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2023012309495650800_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2199-11-74","article-title":"MIQE pr\u00e9cis: practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments","volume":"11","author":"Bustin","year":"2010","journal-title":"BMC Mol Biol"},{"key":"2023012309495650800_bib32","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI33467","article-title":"Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling","volume":"118","author":"Mi","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"2023012309495650800_bib33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1517\/14728214.2011.644786","article-title":"Emerging adenosine receptor agonists\u2014an update","volume":"16","author":"Gao","year":"2011","journal-title":"Expert Opin Emerg Drugs"},{"key":"2023012309495650800_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1124\/jpet.113.210849","article-title":"BAY60-6583 acts as a partial agonist at adenosine A2B receptors","volume":"349","author":"Hinz","year":"2014","journal-title":"J\u00a0Pharmacol Exp Ther"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609518309792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609518309792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/15\/7\/947\/48589343\/jsm_15_7_947.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/15\/7\/947\/48589343\/jsm_15_7_947.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T10:28:06Z","timestamp":1674469686000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/15\/7\/947\/6980668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,8]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,6,8]]},"published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2018.05.003","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,6,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the Role of Adenosine Receptors in the Myofibroblast Transformation in Peyronie\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2018.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}